Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Stryker Corp. | 17 | 0 | 4 | 0 | €313.90 | €331.52 | 5.615% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €60.92 | €80.00 | 31.320% |
| Geron Corp. | 10 | 0 | 2 | 0 | €3.30 | €4.59 | 39.233% |
| Chemed Corp. | 4 | 0 | 0 | 0 | €570.00 | €588.14 | 3.183% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €59.50 | €75.80 | 27.395% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €222.00 | €247.61 | 11.535% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €186.15 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.35 | €2.78 | 106.193% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €1.83 | €3.00 | 64.294% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.59 | €26.01 | 20.456% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €14.06 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.00 | €26.58 | 10.756% |
| Corcept Therapeutics Inc. | 9 | 0 | 2 | 0 | €20.72 | €33.55 | 61.904% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €128.65 | €137.63 | 6.983% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €59.00 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €303.80 | - | - |
| X4 Pharmaceuticals, Inc. | 3 | 0 | 0 | 0 | €1.15 | €2.76 | 140.629% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €69.00 | €86.72 | 25.677% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| United Therapeutics | 15 | 0 | 0 | 0 | €217.50 | €289.92 | 33.297% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.06 | €13.74 | 1195.212% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €6.60 | €8.50 | 28.788% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.00 | €95.79 | 5.269% |
| Esperion Therapeutis.Inc. | 12 | 0 | 3 | 0 | €1.98 | €8.39 | 324.295% |